ARTICLE | Clinical News
GlycoPEG-GCSF: Phase II started
June 30, 2008 7:00 AM UTC
The partners began a double-blind Phase II trial in 200 patients with breast cancer receiving 4 cycles of chemotherapy, to compare 3 dose levels of subcutaneous GlycoPEG-GCSF vs. 6 mg Neulasta pegfil...